Literature DB >> 15055475

Moderate alcohol consumption, glucose metabolism and lipolysis: the effect on adiponectin and tumor necrosis factor alpha.

A Avogaro1, M Sambataro, A Marangoni, A Pianta, R Vettor, C Pagano, M C Marescotti, A Tiengo, G Beltramello.   

Abstract

Moderate alcohol consumption has a cardioprotective effect on coronary artery disease. Among the beneficial effects of alcohol, a suppression of the plasma free fatty acid (FFA) concentration has been shown but the mechanism which accounts for this action is not clear. We assessed whether moderate alcohol intake affects plasma adiponectin levels and tumor necrosis factor (TNF)-alpha, two regulators of lipolysis. Oral glucose tolerance tests were performed twice on 22 volunteers: "the alcohol study" and "control study". In the former, red wine was sipped to maintain steady state alcohol concentration. Samples for plasma glucose, insulin, FFA, adiponectin, and TNF-alpha concentrations were obtained. In the latter, tap water was sipped. Insulin action has been assessed by the Oral Glucose Insulin Sensitivity (OGIS) Model. The mean blood alcohol concentration was 5+/-2 mg/dl. No differences were observed between the two studies in the OGIS (406+/-19 ml x min(-1) x m(-2) with alcohol and 402+/-20 without, respectively). Baseline FFA levels were lower in the alcohol study; however, post-glucose inhibition was comparable. No differences in the TNF-alpha and adiponectin responses were observed. A significant correlation was observed between the OGIS index and the fasting adiponectin level (r=0.589, p<0.0001). Moderate red wine intake improves post-glucose FFA profiles but does not modify the plasma concentrations of both TNF-alpha and of adiponectin concentrations: the latter is significantly and positively associated to the insulin action. Further studies are needed to clarify the antilipolytic effect of moderate alcohol intake.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15055475     DOI: 10.1007/bf03349160

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  35 in total

1.  Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes.

Authors:  M Rosenstock; A S Greenberg; A Rudich
Journal:  Diabetologia       Date:  2001-01       Impact factor: 10.122

2.  Enzymatic microdetermination of serum free fatty acids.

Authors:  S Shimizu; K Inoue; Y Tani; H Yamada
Journal:  Anal Biochem       Date:  1979-10-01       Impact factor: 3.365

3.  Effect of alcohol on exercise-induced changes in serum glucose and serum free fatty acids.

Authors:  E Heikkonen; R Ylikahri; R Roine; M Välimäki; M Härkönen; M Salaspuro
Journal:  Alcohol Clin Exp Res       Date:  1998-04       Impact factor: 3.455

4.  Alcohol, stroke and coronary artery disease.

Authors:  E R Eichner
Journal:  Am Fam Physician       Date:  1988-03       Impact factor: 3.292

5.  Effect of meal frequency on blood glucose, insulin, and free fatty acids in NIDDM subjects.

Authors:  J Bertelsen; C Christiansen; C Thomsen; P L Poulsen; S Vestergaard; A Steinov; L H Rasmussen; O Rasmussen; K Hermansen
Journal:  Diabetes Care       Date:  1993-01       Impact factor: 19.112

6.  Effects of TNF-alpha on glucose metabolism and lipolysis in adipose tissue and isolated fat-cell preparations.

Authors:  Marty H Porter; Alexis Cutchins; Jacqueline B Fine; Yaohui Bai; Mario DiGirolamo
Journal:  J Lab Clin Med       Date:  2002-03

7.  The acute impact of ethanol on glucose, insulin, triacylglycerol,and free fatty acid responses and insulin sensitivity in type 2 diabetes.

Authors:  C Christiansen; C Thomsen; O Rasmussen; C Hansen; K Hermansen
Journal:  Br J Nutr       Date:  1996-11       Impact factor: 3.718

8.  Wine for type 2 diabetic patients?

Authors:  C Christiansen; C Thomsen; O Rasmussen; M Balle; C Hauerslev; C Hansen; K Hermansen
Journal:  Diabet Med       Date:  1993-12       Impact factor: 4.359

9.  The expression of TNF alpha by human muscle. Relationship to insulin resistance.

Authors:  M Saghizadeh; J M Ong; W T Garvey; R R Henry; P A Kern
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  1 in total

Review 1.  Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Authors:  Mark J Niciu; Ioline D Henter; Gerard Sanacora; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-12       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.